Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol

Mann, Eleanor; Prevost, A. Toby; Griffin, Simon; Kellar, Ian; Sutton, Stephen; Parker, Michael; Sanderson, Simon; Kinmonth, Ann Louise; Marteau, Theresa M.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p1
Academic Journal
Background: Screening invitations have traditionally been brief, providing information only about population benefits. Presenting information about the limited individual benefits and potential harms of screening to inform choice may reduce attendance, particularly in the more socially deprived. At the same time, amongst those who attend, it might increase motivation to change behavior to reduce risks. This trial assesses the impact on attendance and motivation to change behavior of an invitation that facilitates informed choices about participating in diabetes screening in general practice. Three hypotheses are tested: 1. Attendance at screening for diabetes is lower following an informed choice compared with a standard invitation. 2. There is an interaction between the type of invitation and social deprivation: attendance following an informed choice compared with a standard invitation is lower in those who are more rather than less socially deprived. 3. Amongst those who attend for screening, intentions to change behavior to reduce risks of complications in those subsequently diagnosed with diabetes are stronger following an informed choice invitation compared with a standard invitation. Method/Design: 1500 people aged 40-69 years without known diabetes but at high risk are identified from four general practice registers in the east of England. 1200 participants are randomized by households to receive one of two invitations to attend for diabetes screening at their general practices. The intervention invitation is designed to facilitate informed choices, and comprises detailed information and a decision aid. A comparison invitation is based on those currently in use. Screening involves a finger-prick blood glucose test. The primary outcome is attendance for diabetes screening. The secondary outcome is intention to change health related behaviors in those attenders diagnosed with diabetes. A sample size of 1200 ensures 90% power to detect a 10% difference in attendance between arms, and in an estimated 780 attenders, 80% power to detect a 0.2 sd difference in intention between arms. Discussion: The DICISION trial is a rigorous pragmatic denominator based clinical trial of an informed choice invitation to diabetes screening, which addresses some key limitations of previous trials.


Related Articles

  • What does it cost to establish a practice-nurses-led clinical trial in general practice? Blackberry, Irene D.; Furler, John S.; Young, Doris; Best, James D. // Medical Journal of Australia;11/2/2009, Vol. 191 Issue 9, p492 

    The article discusses the results of a study to determine the costs of engaging the services of practice nurses (PNs) involved in randomised controlled clinical trials of diabetes in Australia. The role of PNs in primary care research is expected to increase but the costs of employing PNs in...

  • The management of diabetes. Griffin, Simon J // BMJ: British Medical Journal (International Edition);10/27/2001, Vol. 323 Issue 7319, p946 

    Editorial. Focuses on medical care for diabetics. Registration, recall, and regular review as standard treatment for diabetes; Details of a clinical trial from Danish general practice on enhancing the care of diabetes; Ability of primary care to handle diabetes cases.

  • Accuracy of the pain numeric rating scale as a screening test in primary care. Krebs, Erin E.; Carey, Timothy S.; Weinberger, Morris // JGIM: Journal of General Internal Medicine;Oct2007, Vol. 22 Issue 10, p1453 

    Background: Universal pain screening with a 0-10 pain intensity numeric rating scale (NRS) has been widely implemented in primary care.Objective: To evaluate the accuracy of the NRS as a screening test to identify primary care patients with clinically important...

  • The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]. Fletcher, A. E.; Jones, D. A.; Bulpitt, C. J.; Tulloch, A. J. // BMC Health Services Research;2002, Vol. 2, p21 

    Background: The benefit of regular multidimensional assessment of older people remains controversial. The majority of trials have been too small to produce adequate evidence to inform policy. Despite the lack of a firm evidence base, UK primary care practitioners (general practitioners) are...

  • Participation of pharmacists in clinical trial recruitment for low back pain. Abdel Shaheed, Christina; Maher, Christopher; Williams, Kylie; McLachlan, Andrew // International Journal of Clinical Pharmacy;Oct2014, Vol. 36 Issue 5, p986 

    Introduction Clinician involvement in clinical trials research represents a significant contribution to addressing important research questions in primary care. Aim This study aimed to explore the experiences of pharmacists recruiting patients to a low back pain (LBP) clinical trial conducted in...

  • The reduction of disability in community-dwelling frail older people: design of a two-arm cluster randomized controlled trial. Metzelthin, Silke F.; van Rossum, Erik; de Witte, Luc P.; Hendriks, Marike R. C.; Kempen, Gertrudis I. J. M. // BMC Public Health;2010, Vol. 10 Issue 1, p511 

    Background: Frailty among older people is related to an increased risk of adverse health outcomes such as acute and chronic diseases, disability and mortality. Although many intervention studies for frail older people have been reported, only a few have shown positive effects regarding...

  • Diabetes commissioning tool kit.  // GP: General Practitioner;1/26/2007, p18 

    The article reports that a scheme piloting a commissioning tool for diabetes has been introduced in Great Britain. Six Primary Care Trusts are expected to trial the tool kit, which was developed by the Primary Care Diabetes Society and other organizations.

  • Rebuttal. Marshall, Kenneth G. // CMAJ: Canadian Medical Association Journal;6/01/99, Vol. 160 Issue 11, p1595 

    Editorial. Presents a rebuttal by Dr. Marshall to Drs. Gerstein and Meltzer's argument over the issue of screening for diabetes for the general population of Canada. Question whether screening the general population for diabetes is a reasonable recommendation; Lack of clinical trials to prove...

  • Medical Screening and the Value of Early Detection: When Unwarranted Faith Leads to Unethical Recommendations. MALM, H. M. // Hastings Center Report;Jan/Feb99, Vol. 29 Issue 1, p26 

    Discusses the ethical permissibility of the practice of recommending screening tests in the absence of randomized, controlled clinical trials. Consideration on the justifications for the practice of recommending screening tests prior to the completion of randomized clinical trials; Examples of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics